Pacific Biosciences Q3 Adj. EPS $(0.12) Beats $(0.15) Estimate, Sales $38.441M Miss $40.210M Estimate
Benzinga Newsdesk 1 year ago
EarningsEarnings BeatsEarnings MissesNews
Pacific Biosciences (NASDAQ:PACB) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.15) by 22.58 percent. This is a 29.41 percent increase over losses of $(0.17) per share
Pacific Biosciences (NASDAQ:PACB) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.15) by 22.58 percent. This is a 29.41 percent increase over losses of $(0.17) per share from the same period last year. The company reported quarterly sales of $38.441 million which missed the analyst consensus estimate of $40.210 million by 4.40 percent. This is a 3.82 percent decrease over sales of $39.967 million the same period last year.